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DOCKING STUDIES USING PROTEINS INVOLVED lN 
BREAST CANCER ANO LOW MOLECULAR WEIGHT 
COMPOUNDS FOUND lN WILD MUSHROOMS 
Hugo J.C. Froufe, Rui M.V. Abreu , Isabel C.F.R. Ferreira 
Mountain Research Centre, CIMO-ESA, Campus Santa Apolónia, Apartado 1172, 
5301-854 Bragança, Portugal 
Mushrooms are a vast and yet largely untapped source of powerful new pharmaceutical products. 
ln particular, and most importantly for modern medicine, they represent an unlimited source of 
compounds with antitumor and immunostimulating properties [1). Particularly, the intake of some 
wild mushrooms has shown to reduce the risk of breast cancer in Chinese women [2] and inhibited 
the proliferation of human tumour celllines [3]. 
A large number of LMW {low molecular weight) compounds have been identified in wild 
mushrooms including phenolic acids, flavonoids, tocopherols and carotenoids [4]. ln this study we 
used AutoDock4 to perform molecular docking in arder to evaluate which LMW compounds may 
be involved in the inhibition of the activity of proteins related to human breast cancer. The protein 
targets selected were aromatase (EC: 1.14.14.1), estrone sulfatase (EC: 3.1.6.2) and 17-
hydroxysteroid dehydrogenase type 1 activity (17f!.-HSD-1 ; EC: 1.1.1 .62). A representative dataset 
of 43 LMW compounds was selected and molecular docking was performed against the three 
protein targets. 4-0-caffeoylquinic, naringin and lycopene stand out as the top ranked potential 
inhibitors for aromatase, estrone sulfatase and 17r..-HSD1, respectively. Ali the compounds with 
good estimated Ki (inhibition constant) values were manually inspected in arder to investigate the 
binding mode to the catalytic site of each protein target. 
This study suggests the LMW compounds to look for in wild mushrooms when searching for 
species with anti-breast cancer activity. Furthermore, the information provided shows severa! 
interesting starting points for further development of Aromatase, Estrone Sulfatase and 17f!.-HSD1 
inhibitors, as also for the development of nutraceuticals or functional foods . 
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